Citation: Ld. Moaven, SHOULD WE BE SCREENING BLOOD-DONORS FOR HEPATITIS-G VIRUS - THE CASE FOR SCREENING, Medical journal of Australia, 169(7), 1998, pp. 373-374
Authors:
MOAVEN LD
LOCARNINI SA
BOWDEN DS
KIM JP
BRESCHKIN A
MCCAW R
YUN A
WAGES J
JONES B
ANGUS P
Citation: Ld. Moaven et al., HEPATITIS-G VIRUS AND FULMINANT HEPATIC-FAILURE - EVIDENCE FOR TRANSFUSION-RELATED INFECTION, Journal of hepatology, 27(4), 1997, pp. 613-619
Authors:
MOAVEN LD
YOUNG IF
BOWDEN DS
LOCARNINI SA
Citation: Ld. Moaven et al., PREVALENCE OF HEPATITIS-G VIRUS-ANTIBODIES IN QUEENSLAND BLOOD-DONORS, Medical journal of Australia, 166(9), 1997, pp. 507
Citation: Ld. Moaven et al., THE CHANGING PREVALENCE OF HEPATITIS-C VIRUS TYPES IN INJECTING DRUG-USERS BETWEEN 1971 AND 1994, Medical journal of Australia, 165(4), 1996, pp. 233-233
Citation: Mlk. Tang et al., PARVOVIRUS B19-ASSOCIATED RED-BLOOD-CELL APLASIA IN COMBINED IMMUNODEFICIENCY WITH NORMAL IMMUNOGLOBULINS, The Pediatric infectious disease journal, 13(6), 1994, pp. 539-542
Citation: Ld. Moaven et al., HEPATITIS-C VIRUS-INFECTION IN VICTORIAN INJECTING DRUG-USERS IN 1971, Medical journal of Australia, 158(8), 1993, pp. 574-574